Mutational biosynthesis of butirosin analogs. I. Conversion of neamine analogs into butirosin analogs by mutants of Bacillus circulans.
By N-methyl-N'-nitro-N-nitrosoguanidine treatment, neamine-negative mutants which required neamine for biosynthesis of butirosins were obtained from a butirosin-producing organism Bacillus circulans. These mutants also produced butirosins from paromamine and could be divided into two types I and II. Mutants of type I could not produce butirosins from 2-deoxystreptamine, whereas those of type II could. Two typical mutants MCRL 5003 (type I) and MCRL 5004 (type II) could produce butirosin analogs, 3', 4'-dideoxybutirosins, 6'-N-methylbutirosins, 3', 4'-dideoxy-6'-N-methylbutirosins and 3', 4'-dideoxy-6'-C-methyl-butirosins from neamine analogs, gentamine Cla, 6'-N-methylneamine, 6'-N-methylgentamine Cla and gentamine C2, respectively.
D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D001407:Bacillus / Q000235:genetics / Q000378:metabolism*; D001711:Biotransformation; D002076:Butirosin Sulfate / Q000096:biosynthesis* / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D005285:Fermentation; D009154:Mutation; D009355:Neomycin / Q000031:analogs & derivatives* / Q000378:metabolism; D013997:Time Factors
D000900:Anti-Bacterial Agents; D002076:Butirosin Sulfate; D009355:Neomycin